Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy
Linagliptin has protective effects on the retinal neurovascular unit but, in proliferative retinopathy, dipeptidyl peptidase 4 (DPP-4) inhibition could be detrimental. The aim of this study was to assess the effect of linagliptin on ischaemiainduced neovascularisation of the retina.
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 August 2018
|
| In: |
Diabetologia
Year: 2018, Jahrgang: 61, Heft: 11, Pages: 2412-2421 |
| ISSN: | 1432-0428 |
| DOI: | 10.1007/s00125-018-4701-4 |
| Online-Zugang: | Resolving-System, Volltext: https://doi.org/10.1007/s00125-018-4701-4 Verlag: https://link.springer.com/article/10.1007%2Fs00125-018-4701-4 
|
| Verfasserangaben: | Matthias Kolibabka, Nadine Dietrich, Thomas Klein, Hans-Peter Hammes |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1685477410 | ||
| 003 | DE-627 | ||
| 005 | 20220817184726.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191213s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00125-018-4701-4 |2 doi | |
| 035 | |a (DE-627)1685477410 | ||
| 035 | |a (DE-599)KXP1685477410 | ||
| 035 | |a (OCoLC)1341282112 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kolibabka, Matthias |d 1989- |e VerfasserIn |0 (DE-588)1078055289 |0 (DE-627)837983169 |0 (DE-576)448887258 |4 aut | |
| 245 | 1 | 0 | |a Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy |c Matthias Kolibabka, Nadine Dietrich, Thomas Klein, Hans-Peter Hammes |
| 264 | 1 | |c 10 August 2018 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.12.2019 | ||
| 520 | |a Linagliptin has protective effects on the retinal neurovascular unit but, in proliferative retinopathy, dipeptidyl peptidase 4 (DPP-4) inhibition could be detrimental. The aim of this study was to assess the effect of linagliptin on ischaemiainduced neovascularisation of the retina. | ||
| 650 | 4 | |a Angiogenesis | |
| 650 | 4 | |a DPP-4 | |
| 650 | 4 | |a GLP-1 | |
| 650 | 4 | |a Linagliptin | |
| 650 | 4 | |a Oxygen-induced retinopathy | |
| 650 | 4 | |a Proliferative retinopathy | |
| 700 | 1 | |a Dietrich, Nadine |d 1977- |e VerfasserIn |0 (DE-588)1072657120 |0 (DE-627)827961278 |0 (DE-576)434162302 |4 aut | |
| 700 | 1 | |a Hammes, Hans-Peter |d 1955- |e VerfasserIn |0 (DE-588)102028353X |0 (DE-627)691169772 |0 (DE-576)360007252 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetologia |d Berlin : Springer, 1965 |g 61(2018), 11, Seite 2412-2421 |h Online-Ressource |w (DE-627)253722209 |w (DE-600)1458993-X |w (DE-576)072372354 |x 1432-0428 |7 nnas |a Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy |
| 773 | 1 | 8 | |g volume:61 |g year:2018 |g number:11 |g pages:2412-2421 |g extent:10 |a Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00125-018-4701-4 |x Resolving-System |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007%2Fs00125-018-4701-4 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191213 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 102028353X |a Hammes, Hans-Peter |m 102028353X:Hammes, Hans-Peter |d 60000 |d 61400 |e 60000PH102028353X |e 61400PH102028353X |k 0/60000/ |k 1/60000/61400/ |p 4 |y j | ||
| 998 | |g 1072657120 |a Dietrich, Nadine |m 1072657120:Dietrich, Nadine |d 60000 |d 61400 |e 60000PD1072657120 |e 61400PD1072657120 |k 0/60000/ |k 1/60000/61400/ |p 2 | ||
| 998 | |g 1078055289 |a Kolibabka, Matthias |m 1078055289:Kolibabka, Matthias |d 60000 |d 61400 |e 60000PK1078055289 |e 61400PK1078055289 |k 0/60000/ |k 1/60000/61400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1685477410 |e 3564645411 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"10 August 2018","dateIssuedKey":"2018"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"10 S."}],"person":[{"given":"Matthias","roleDisplay":"VerfasserIn","role":"aut","display":"Kolibabka, Matthias","family":"Kolibabka"},{"given":"Nadine","roleDisplay":"VerfasserIn","role":"aut","display":"Dietrich, Nadine","family":"Dietrich"},{"given":"Hans-Peter","roleDisplay":"VerfasserIn","role":"aut","family":"Hammes","display":"Hammes, Hans-Peter"}],"title":[{"title":"Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy","title_sort":"Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathy"}],"note":["Gesehen am 13.12.2019"],"id":{"eki":["1685477410"],"doi":["10.1007/s00125-018-4701-4"]},"relHost":[{"part":{"volume":"61","year":"2018","extent":"10","issue":"11","text":"61(2018), 11, Seite 2412-2421","pages":"2412-2421"},"language":["eng"],"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"European Association for the Study of Diabetes"}],"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1965","dateIssuedDisp":"1965-","publisher":"Springer"}],"title":[{"subtitle":"journal of the European Association for the Study of Diabetes (EASD)","title":"Diabetologia","title_sort":"Diabetologia"}],"pubHistory":["1.1965/66 -"],"id":{"issn":["1432-0428"],"zdb":["1458993-X"],"eki":["253722209"]},"note":["Gesehen am 27. November 2017","Ungezählte Beil.: Supplement"],"recId":"253722209","disp":"Anti-angiogenic effects of the DPP-4 inhibitor linagliptin via inhibition of VEGFR signalling in the mouse model of oxygen-induced retinopathyDiabetologia","type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}]}],"recId":"1685477410","language":["eng"],"name":{"displayForm":["Matthias Kolibabka, Nadine Dietrich, Thomas Klein, Hans-Peter Hammes"]}} | ||
| SRT | |a KOLIBABKAMANTIANGIOG1020 | ||